APA (7th ed.) Citation

F, W., J, H., H, M., D, P., V, K., JS, L., . . . J, X. (2026). Intravenous administration of an engineered AAV9-gene-silencing vector suppresses human SOD1 and extends survival in an ALS mouse model. Nature communications, 17(1), . https://doi.org/10.1038/s41467-026-74169-8

Chicago Style (17th ed.) Citation

F, Wan, et al. "Intravenous Administration of an Engineered AAV9-gene-silencing Vector Suppresses Human SOD1 and Extends Survival in an ALS Mouse Model." Nature Communications 17, no. 1 (2026). https://doi.org/10.1038/s41467-026-74169-8.

MLA (9th ed.) Citation

F, Wan, et al. "Intravenous Administration of an Engineered AAV9-gene-silencing Vector Suppresses Human SOD1 and Extends Survival in an ALS Mouse Model." Nature Communications, vol. 17, no. 1, 2026, https://doi.org/10.1038/s41467-026-74169-8.